You are here: Industry Insights > GlobalData

News List

Antibodies against SARS-CoV-2 wane over time, suggesting immunity may be short-lived: GlobalData expresspharma
October 29, 2020
Following new data from Imperial College London (ICL) suggesting that antibody levels against SARS-CoV-2 wane over time; Michael Breen, Director of Infectious Diseases and Ophthalmology at GlobalData offers his view.
India’s role in global supply of COVID-19 drugs and vaccines remains crucial despite IPR waiver decision: GlobalData expresspharma
October 22, 2020
Following the news that the US and EU have blocked India’s fight for intellectual property rights (IPR) waiver for COVID-19 drugs; Prashant Khadayate, Pharma Analyst at GlobalData, offers his view.
Vaccine trials outside home market will help Chinese firms capture Asia, South and Central America markets: GlobalData expresspharma
October 19, 2020
Pharma companies across the globe are working to develop a vaccine against COVID-19, which has already infected more than 38 million globally.
Remdesivir price curbs in India make COVID-19 treatment more affordable: GlobalData expresspharma
October 19, 2020
Maharashtra has fixed the price of remdesivir at Rs 2,360, 16 per cent more economical than the cheapest brand Remdac at Rs 2,800 by Zydus Cadila and 56 per cent more economical than Covifor at Rs 5,400 by Hetero Labs.
Biopharma companies more optimistic about 2020 imports/exports than in Q1: GlobalData expresspharma
October 19, 2020
API manufacturing still remains a greater concern than finished dose due to the high volume of small molecule API produced in China and India for cost reasons.
COVID-19 clinical trial disruption declines but trials continue to suffer from slow recruitment expresspharma
October 15, 2020
Trials impacted by enrolment suspension have been on a downward trajectory, while the number of clinical trials with delayed initiation have remained steady.
Indian dose sites untapped M&A opportunity for foreign CMOs: GlobalData expresspharma
October 09, 2020
Only six US, five UK, and three German CMOs own solid dose manufacturing sites in India.
Bispecific antibodies will mature after 2021, $6bn estimated sales in oncology by 2025: GlobalData expresspharma
October 09, 2020
There are 106 bispecific antibody molecules in the pipeline and 263 ongoing/planning to enrol clinical trials involving a bispecific antibody.
Global opioid use disorder market to reach $3.7 bn by 2028: GlobalData expresspharma
September 27, 2020
The main driver of growth will be the launch of reformulations of buprenorphine, in particular, extended-release formulations.
Informing payers and patients of biological therapy advantages can strengthen biosimilars market expresspharma
September 23, 2020
Patients are unaware of the cost savings and payers are unclear if they can replace the reference biologics with the biosimilar drugs, says a GlobalData report.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page